Nuformix Expands NXP001 Agreement With Additional Pre-Clinical Study
LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC said on Tuesday it has expanded its current licensing agreement with partner Newsummit Biopharma for the development of cancer Read More